Literature for peptidase C01.077: falcipain-1

(References are filtered for relevance to Inhibitor. To remove the filter click here. See explanation.)

2019
1. Vieira,R.P., Santos,V.C. and Ferreira,R.S.
   Structure-based approaches targeting parasite cysteine proteases
   Curr Med Chem (2019) 26, 4435-4453. PubMed  Europe PubMed DOI  I
2018
2. Bekono,B.D., Ntie-Kang,F., Owono Owono,L.C. and Megnassan,E.
   Targeting cysteine proteases from Plasmodium falciparum: a general overview, rational drug design and computational approaches for drug discovery
   Curr Drug Targets (2018) 19, 501-526. PubMed  Europe PubMed DOI  I
2010
3. Shah,F., Mukherjee,P., Desai,P. and Avery,M.
   Computational approaches for the discovery of cysteine protease inhibitors against malaria and SARS
   Curr Comput Aided Drug Des (2010) 6, 1-23. PubMed  Europe PubMed DOI  I
2006
4. [YEAR:11-4-2006]Verhelst,S.H., Witte,M.D., Arastu-Kapur,S., Fonovic,M. and Bogyo,M.
   Novel aza peptide inhibitors and active-site probes of papain-family cysteine proteases
   Chembiochem (11-4-2006) 7, 943-950. PubMed  Europe PubMed DOI  I
2004
5. [YEAR:15-9-2004]Na,B.K., Kim,T.S., Rosenthal,P.J., Lee,J.K. and Kong,Y.
   Evaluation of cysteine proteases of Plasmodium vivax as antimalarial drug targets: sequence analysis and sensitivity to cysteine protease inhibitors
   Parasitol Res (15-9-2004) 94, 312-317. PubMed  Europe PubMed DOI  I
1996
6. Rosenthal,P.J., Olson,J.E., Lee,G.K., Palmer,J.T., Klaus,J.L. and Rasnick,D.
   Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors
   Antimicrobial Agents Chemother (1996) 40, 1600-1603. PubMed  Europe PubMed  PMC  EPMC  I